Synthalin
Synthalin was an oral anti-diabetic drug. Discovered in 1926 it was marketed in Europe by Schering AG of Berlin as a synthetic drug with insulin-like properties that could be taken orally. However, it was toxic to the liver and kidney and was withdrawn from the market in the early 1940s.
Wikipedia contributors, "Synthalin", Wikipedia, revision 1329692092, retrieved 20 November 2026, source, CC BY-SA 4.0.